The Journal of Antibiotics · 1994 · 57 citations · 9 references
Life SciencesBiochemistryMicrobiologyDrug DiscoveryMycologyAntifungal AgentsAntifungal ResistanceAntifungal PeptidesNatural Antifungal CompoundsNew Antifungal Agents
WF11899A, B and C, novel water-soluble lipopeptides related to the echinocandins, possess potent anti-Candida activities. The IC50s of the compounds against four clinical isolates of Candida albicans ranged from 0.004 to 0.03 microgram/ml by microbroth dilution assay. These compounds mildly suppressed the growth of Aspergillus fumigatus and A. niger. WF11899A, B and C showed a potent in vivo anti-Candida activity. Particularly, WF11899A was superior to cilofungin, and equal to fluconazole. 1,3-beta-glucan synthase was inhibited by these compounds at the IC50s of 0.7, 0.7 and 1.8 micrograms/ml for WF11899A, B and C, respectively. However, they hemolysed mouse red blood cells in vitro at the concentration of 62 micrograms/ml.
9
In vitro and in vivo anti-Candida activity and toxicology of LY121019.
Robert S. Gordee, Douglas J. Zeckner, L. F. Ellis et al. · The Journal of Antibiotics · 1984 · 109 citations · Full text
Deacylation of echinocandin B by Actinoplanes utahensis.
LA VERNE D. BOECK, D. S. Fukuda, Bernard J. Abbott et al. · The Journal of Antibiotics · 1989 · 88 citations
Studies on the mechanism of antifungal action of aculeacin A.
Hideyo Yamaguchi, Tamio Hiratani, Kazuo Iwata et al. · The Journal of Antibiotics · 1982 · 80 citations · Full text